HTG Molecular Diagnostics Inc (HTGM.OQ)
HTGM.OQ on NASDAQ Stock Exchange Capital Market
3.54USD
2:35pm EDT
3.54USD
2:35pm EDT
Change (% chg)
$-0.01 (-0.28%)
$-0.01 (-0.28%)
Prev Close
$3.55
$3.55
Open
$3.55
$3.55
Day's High
$3.58
$3.58
Day's Low
$3.48
$3.48
Volume
60,779
60,779
Avg. Vol
175,114
175,114
52-wk High
$5.82
$5.82
52-wk Low
$1.59
$1.59
Consensus Recommendations
| Consensus Recommendation | Next Earnings (approx.) | Company Fiscal Year End Month |
Last Updated |
|---|---|---|---|
| Buy | -0.18 | December | 19 Jun 2018 |
Analyst Recommendations and Revisions
| 1-5 Linear Scale | Current | 1 Month Ago |
2 Month Ago |
3 Month Ago |
|---|---|---|---|---|
| (1) BUY | 1 | 1 | 1 | 1 |
| (2) OUTPERFORM | 1 | 1 | 1 | 1 |
| (3) HOLD | 0 | 0 | 0 | 0 |
| (4) UNDERPERFORM | 0 | 0 | 0 | 0 |
| (5) SELL | 0 | 0 | 0 | 0 |
| No Opinion | 0 | 0 | 0 | 0 |
| Mean Rating | 1.50 | 1.50 | 1.50 | 1.50 |
Consensus Estimates Analysis
Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
| # of Estimates | Mean | High | Low | 1 Year Ago |
|
|---|---|---|---|---|---|
| SALES (in millions) | |||||
| Quarter Ending Jun-18 | 2 | 5.28 | 5.30 | 5.26 | 3.05 |
| Quarter Ending Sep-18 | 2 | 5.24 | 5.30 | 5.17 | 3.20 |
| Year Ending Dec-18 | 2 | 23.00 | 23.00 | 23.00 | 12.50 |
| Year Ending Dec-19 | 2 | 31.42 | 31.84 | 31.00 | -- |
| Earnings (per share) | |||||
| Quarter Ending Jun-18 | 2 | -0.18 | -0.17 | -0.19 | -0.44 |
| Quarter Ending Sep-18 | 2 | -0.21 | -0.18 | -0.24 | -0.48 |
| Year Ending Dec-18 | 2 | -0.74 | -0.66 | -0.82 | -1.72 |
| Year Ending Dec-19 | 2 | -0.60 | -0.48 | -0.71 | 20.50 |
Historical Surprises
Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
| Estimates vs Actual | Estimate | Actual | Difference | Surprise % |
|---|---|---|---|---|
| SALES (in millions) | ||||
| Quarter Ending Mar-18 | 4.97 | 4.16 | 0.81 | 16.35 |
| Quarter Ending Dec-17 | 6.97 | 7.90 | 0.93 | 13.32 |
| Quarter Ending Sep-17 | 2.90 | 3.72 | 0.82 | 28.40 |
| Quarter Ending Jun-17 | 1.70 | 1.76 | 0.06 | 3.53 |
| Quarter Ending Mar-17 | 1.97 | 1.37 | 0.60 | 30.44 |
Consensus Estimates Trend
Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
| Current | 1 Week Ago |
1 Month Ago |
2 Month Ago |
1 Year Ago |
|
|---|---|---|---|---|---|
| SALES (in millions) | |||||
| Quarter Ending Jun-18 | 5.28 | 5.28 | 5.28 | 5.47 | 3.05 |
| Quarter Ending Sep-18 | 5.24 | 5.24 | 5.24 | 5.82 | 3.20 |
| Year Ending Dec-18 | 23.00 | 23.00 | 23.00 | 22.50 | 12.50 |
| Year Ending Dec-19 | 31.42 | 31.42 | 31.42 | 31.00 | -- |
Estimates Revisions Summary
| Last Week | Last 4 Weeks | |||
|---|---|---|---|---|
| Number Of Revisions: | Up | Down | Up | Down |
| Revenue | ||||
| Quarter Ending Jun-18 | 0 | 0 | 0 | 0 |
| Quarter Ending Sep-18 | 0 | 0 | 0 | 0 |
| Year Ending Dec-18 | 0 | 0 | 0 | 0 |
| Year Ending Dec-19 | 0 | 0 | 0 | 0 |
| Earnings | ||||
Earnings vs. 
Estimates- BRIEF-HTG Promotes John Lubniewski To President And Chief Operating Officer
- BRIEF-HTG Molecular Diagnostics Inc Says On March 30, 2018, Co And Qiagen Manchester Limited Entered Second Amendment Of First Statement Of Work
- BRIEF-Htg Molecular Diagnostics Secures Debt Facility With Midcap Financial
- BRIEF-HTG Molecular Q4 Loss Per Share $0.15
- BRIEF-Stonepine Capital Management Reports 5.6 Pct Passive Stake In HTG Molecular Diagnostics